SIGNAFUSE Bioactive Bone Graft - SIGNAFUSE Bioactive Bone Graft is a bioactive - BIOVENTUS LLC

Duns Number:078450878

Device Description: SIGNAFUSE Bioactive Bone Graft is a bioactive bone graft substitute comprising biphasic mi SIGNAFUSE Bioactive Bone Graft is a bioactive bone graft substitute comprising biphasic mineral granules and 45S5 bioactive glass suspended in a porous type I collagen matrix. The device is provided sterile and is to be combined with autologous bone marrow aspirate prior to use to facilitate packing into bony defects. The device provides an osteoconductive scaffold that resorbs and guides host bone regeneration during the healing process.

Want to know more about this Product? Request more information now!


More Product Details

Catalog Number

SGFS-010

Brand Name

SIGNAFUSE Bioactive Bone Graft

Version/Model Number

50X25X8 MM, 10 CC

Device Commercial Distribution Status

In Commercial Distribution

Commercial Distribution End Date

-

Issuing Agency

In GS1

Product Characteristics

MRI safety Status

Labeling does not contain MRI Safety Information

Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)

-

Device labeled as "Not made with natural rubber latex"

-

For Single-Use

Yes

Prescription Use (Rx)

Yes

Over the Counter (OTC)

-

Kit

-

Combination Product

-

Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)

-

FDA Premarket Submission

K193513

Product Code Details

Product Code

MQV

Product Code Name

Filler, Bone Void, Calcium Compound

Device Record Status

Public Device Record Key

afa7e5a3-f627-4a21-9f3e-fa3bedac3495

Public Version Date

August 07, 2020

Public Version Number

1

DI Record Publish Date

July 30, 2020

Additional Identifiers

Package DI Number

None

Quantity per Package

-

Contains DI Package

-

Package Discontinue Date

-

Package Status

-

Package Type

-

"BIOVENTUS LLC" Characteristics
Device Class Device Class Description No of Devices
2 A medical device with a moderate to high risk that requires special controls. 16
3 A medical device with high risk that requires premarket approval 5